Alden acquires Fluoresoft, launches new practice finder tool

Article

Alden Optical recently acquired Fluoresoft, the only high molecular weight fluorescent solution available in the U.S., from Holles Laboratories, Inc.

Lancaster, NY-Alden Optical recently acquired Fluoresoft, the only high molecular weight fluorescent solution available in the U.S., from Holles Laboratories, Inc. The solution can be used to evaluate the cornea-to-lens fitting relationship, assess epithelial abnormalities due to contact lens wear, and assist during applanation tonometry. Fluoresoft’s high molecular weight compound prevents absorption by soft lens materials, preventing lens staining, according to the company.

In related news, Alden launched the Astera Multifocal Toric Practice Locator Tool. The map tool allows patients to locate practices offering the Astera Multifocal Toric lenses, which the company says is ideal for patients with astigmatism who don’t want to give up soft contact lenses as they become presyopic. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.